On one hand there are previous studies indicating that medications that prevent the breakdown of acetylcholine (i.e., cholinesterase inhibitors) improve cognition in demented patients with PD (Emre et al., 2004; Bosboom et al., 2009; Possin et al., 2013). The gene discussed is BCHE; the disease is Parkinson disease.